Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBIT vs GSK✓SelectedUSD · GSKIBIT vs GSK performance historyLatest closeAs of-3.52%11/13
Stock and ETF performance explorer

IBIT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.2%
GSK return
+42.3%
Excess return
+3.9%
Maximum drawdown
-53.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.5%+0.5%-4.0%-3.5%
7D-9.2%+1.1%-10.3%-9.2%
30D-15.8%+6.3%-22.1%-15.6%
3M+8.5%+1.8%+6.7%+8.6%
6M-13.7%+1.7%-15.4%-13.6%
YTD-21.6%+6.5%-28.1%-21.1%
1Y-30.0%+9.5%-39.4%-29.5%
All+46.2%+42.3%+3.9%+49.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling